Table 4

The association between metabolic syndrome and subtypes of oral potentially malignant disorders using multivariable Poisson regression

LeukoplakiaOSFVerrucous hyperplasiaErythroplakia
aRR*95% CIaRR†95% CIaRR‡95% CIaRR‡95% CI
Metabolic syndrome
 Yes vs no1.371.14 to 1.641.220.87 to 1.711.330.51 to 3.461.590.67 to 3.75
Component of metabolic syndrome
 Central obesity1.31.07 to 1.571.060.74 to 1.521.170.47 to 2.890.940.37 to 2.36
 Hypertriglyceridaemia1.291.06 to 1.571.210.83 to 1.760.980.40 to 2.401.390.54 to 3.58
 Low HDL-C1.170.97 to 1.420.940.64 to 1.380.790.31 to 1.991.180.47 to 2.97
 Elevated blood pressure0.90.75 to 1.090.950.66 to 1.371.340.46 to 3.851.220.50 to 3.00
 Hyperglycaemia1.160.96 to 1.411.430.99 to 2.051.280.52 to 3.190.990.37 to 2.64
Metabolic syndrome score1.161.09 to 1.241.10.98 to 1.241.020.68 to 1.541.130.83 to 1.55
  • *aRR for metabolic syndrome, components of metabolic syndrome and metabolic syndrome score were treated in different models with adjustment of age, sex, education level, betel nut chewing, cigarette smoking, alcohol drinking, meat, vegetable and fruit consumption.

  • †aRR for metabolic syndrome, components of metabolic syndrome and metabolic syndrome score were treated in different models with adjustment of age, sex, education level, betel nut chewing, cigarette smoking, alcohol drinking, meat and fruit consumption.

  • ‡aRR for metabolic syndrome, components of metabolic syndrome and metabolic syndrome score were treated in different models with adjustment of betel nut chewing and cigarette smoking.

  • aRR, adjusted rate ratio; HDL-C, high-density lipoprotein cholesterol; OSF, oral submucous fibrosis.